Showing results (61-70 of 576) with videos related to
Sort By:
Pageof 58
European Journal of Cancer (Oxford, England : 1990)|August 1, 2009
Current perspective: bevacizumab in colorectal cancer--a time for reappraisal?Alicia Okines, David CunninghamClinical Colorectal Cancer|April 12, 2008
A retrospective on the inhibition of epidermal growth factor receptor as a therapeutic strategy for patients with relapsed metastatic colorectal cancer: impact on treatment of today's patientsChristopher Jackson, David CunninghamJournal of Geriatric Oncology|February 4, 2014
Bevacizumab in elderly patients with metastatic colorectal cancerFrancesco Sclafani, David CunninghamFrontiers in Oncology|June 6, 2020
Predictive Biomarkers of Immune Checkpoint Inhibition in Gastroesophageal CancersRaghav Sundar, Elizabeth C Smyth, Siyu Peng, et al.The Lancet. Oncology|August 30, 2024
Improving individualised therapies in localised gastro-oesophageal adenocarcinomaMagali Svrcek, Thibault Voron, Thierry André, et al.Lancet (London, England)|August 31, 2020
Gastric cancerElizabeth C Smyth, Magnus Nilsson, Heike I Grabsch, et al.Oncology|November 23, 2005
Managing patients treated with bevacizumab combination therapyMichael S Gordon, David CunninghamJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2005
Adjuvant treatment for resectable pancreatic cancerYu Jo Chua, David CunninghamClinical Colorectal Cancer|December 13, 2005
Recent data with anti-epidermal growth factor receptor antibodies and irinotecan in colon cancerYu Jo Chua, David CunninghamClinical Colorectal Cancer|April 26, 2006
Neoadjuvant treatment of unresectable liver metastases from colorectal cancerYu Jo Chua, David CunninghamPageof 58